← Leaderboards
Brandon Lyon Jutras
Virginia Polytechnic Inst And St Univ
$4,090,830
Attributed
$4,090,830
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,090,830 · 4
By mechanism
R01$3,201,334 · 2
R21$889,496 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Cell Wall”
- Terry Roemer · Prokaryotics, Inc.$7,866,387
- Magali Noval Rivas · Cedars-Sinai Medical Center$5,639,049
- Som Chatterjee · University Of Maryland Baltimore$4,311,836
- Krishnakumar Kizhatil · Columbia University Health Sciences$4,080,371
- Tobias Doerr · Cornell University$3,917,047
- Tendy Chiang · Research Inst Nationwide Children'S Hosp$3,672,010
Research focus
Cell WallResearch PersonnelEnvironmentAntibiotic TherapyLyme DiseaseGrowthBacteriaPeptidoglycanInfectionAnimalsLabelMouse ModelLeadChronicLyme ArthritisOralBorrelia BurgdorferiDiagnosisArthritisImmune ResponseIntravenousBorreliaAntibioticsAcute
Grant awards (11)
The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts$514,496
R01 · FY2025 · AI · contact PI
Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease$512,391
R01 · FY2025 · AI · contact PI
Released peptidoglycan fragments are a biomarker for early stages of syphilis$196,636
R21 · FY2025 · AI · contact PI
The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts$558,562
R01 · FY2024 · AI · contact PI
Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease$541,558
R01 · FY2024 · AI · contact PI
Released peptidoglycan fragments are a biomarker for early stages of syphilis$251,918
R21 · FY2024 · AI · contact PI
Released peptidoglycan fragments are a biomarker for early stages of syphilis$1
R21 · FY2024 · AI · contact PI
The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts$561,872
R01 · FY2023 · AI · contact PI
Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease$512,455
R01 · FY2023 · AI · contact PI
Detecting released peptidoglycan fragments as a biomarker for direct diagnosis of acute and chronic Lyme disease$192,879
R21 · FY2022 · AI · contact PI
Detecting released peptidoglycan fragments as a biomarker for direct diagnosis of acute and chronic Lyme disease$248,062
R21 · FY2021 · AI · contact PI